You are here

  • Home
  • Archive
  • Volume 6, Issue 2
  • Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction

Article metrics

Article menu

Download PDFPDF

XML
Rheumatoid arthritis
Original research
Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction

 

Online download statistics by month:

Online download statistics by month: July 2020 to February 2023

AbstractFullPdf
Jul 202011011037
Aug 2020345340136
Sep 202014013739
Oct 2020736939
Nov 2020727040
Dec 2020545112
Jan 2021353410
Feb 2021333213
Mar 2021434326
Apr 2021333314
May 2021393214
Jun 2021393916
Jul 2021424119
Aug 2021535122
Sep 2021252520
Oct 2021302930
Nov 2021222223
Dec 2021242418
Jan 2022211722
Feb 2022363718
Mar 2022323111
Apr 2022394021
May 2022313113
Jun 202229298
Jul 202234379
Aug 202229304
Sep 2022282812
Oct 2022272713
Nov 2022313012
Dec 202215155
Jan 2023262621
Feb 202340399
Total16301599706